Carcinogenesis, Vol. 20, No. 4, 657-662,
April 1999
© 1999 Oxford University Press
High frequency of codon 61 K-ras A
T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene
Environmental Toxicology Program and
1 Environmental Carcinogenesis Program, National Institute of Environmental Health Sciences, PO Box 12233, Research Triangle Park, NC 27709, USA
Chloroprene is the 2-chloro analog of 1,3-butadiene, a potent carcinogen in laboratory animals. Following 2 years of inhalation exposure to 12.8, 32 or 80 p.p.m. chloroprene, increased incidences of lung and Harderian gland (HG) neoplasms were observed in B6C3F1 mice at all exposure concentrations. The present study was designed to characterize genetic alterations in the K- and H-ras protooncogenes in chloroprene-induced lung and HG neoplasms. K-ras mutations were detected in 80% of chloroprene-induced lung neoplasms (37/46) compared with only 30% in spontaneous lung neoplasms (25/82). Both K- and H-ras codon 61 A
T transversions were identified in 100% of HG neoplasms (27/27) compared with a frequency of 56% (15/27) in spontaneous HG neoplasms. The predominant mutation in chloroprene-induced lung and HG neoplasms was an A
T transversion at K-ras codon 61. This mutation has not been detected in spontaneous lung tumors of B6C3F1 mice and was identified in only 7% of spontaneous HG neoplasms. In lung neoplasms, greater percentages (80 and 71%) of A
T transversions were observed at the lower exposures (12.8 and 32 p.p.m.), respectively, compared with 18% at the high exposure. In HG neoplasms, the percentage of A
T transversions was the same at all exposure concentrations. The chloroprene-induced ras mutation spectra was similar to that seen with isoprene, where the predominant base change was an A
T transversion at K-ras codon 61. This differed from 1,3-butadiene, where K-ras codon 13 G
C transitions and H-ras codon 61 A
G transitions were the predominant mutations. The major finding of K-ras A
T transversions in lung and Harderian gland neoplasms suggests that this mutation may be important for tumor induction by this class of carcinogens.
Abbreviations: H & E, hematoxylin and eosin; HG, Harderian gland; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; SSCP, single-stranded conformational polymorphism analysis.
2 To whom correspondence should be addressed Email: sills{at}niehs.nih.gov
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H.-H. L. Hong, T.-V. T. Ton, Y. Kim, N. Wakamatsu, N. P. Clayton, P.-C. Chan, R. C. Sills, and S. A. Lahousse Genetic Alterations in K-ras and p53 Cancer Genes in Lung Neoplasms from B6C3F1 Mice Exposed to Cumene Toxicol Pathol, July 1, 2008; 36(5): 720 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wakamatsu, T. R. devereux, H.-H. L. Hong, and R. C. Sills Overview of the Molecular Carcinogenesis of Mouse Lung Tumor Models of Human Lung Cancer Toxicol Pathol, January 1, 2007; 35(1): 75 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-H. L. Hong, C. D. Houle, T.-V. T. Ton, and R. C. Sills K-ras Mutations in Lung Tumors and Tumors from Other Organs are Consistent with a Common Mechanism of Ethylene Oxide Tumorigenesis in the B6C3F1 Mouse Toxicol Pathol, January 1, 2007; 35(1): 81 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Houle, T.-V. T. Ton, N. Clayton, J. Huff, H.-H. L. Hong, and R. C. Sills Frequent p53 and H-ras Mutations in Benzene- and Ethylene Oxide-Induced Mammary Gland Carcinomas from B6C3F1 Mice Toxicol Pathol, October 1, 2006; 34(6): 752 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Jackson, I. Lea, A. Rashid, S. D. Peddada, and J. K. Dunnick Genetic Alterations in Cancer Knowledge System: Analysis of Gene Mutations in Mouse and Human Liver and Lung Tumors Toxicol. Sci., April 1, 2006; 90(2): 400 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.C. Sills, H.L. Hong, G. Flake, C. Moomaw, N. Clayton, G.A. Boorman, J. Dunnick, and T.R. Devereux o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis Carcinogenesis, April 1, 2004; 25(4): 605 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Devereux, W. Holliday, C. Anna, N. Ress, J. Roycroft, and R. C. Sills Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years Carcinogenesis, October 1, 2002; 23(10): 1737 - 1743. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Hayashi, H.-H. L. Hong, K. Toyoda, T.-V. T. Ton, T. R. Devereux, R. R. Maronpot, J. Huff, and R. C. Sills High Frequency of Ras Mutations in Forestomach and Lung Tumors of B6C3F1 Mice Exposed to 1-Amino-2,4-dibromoanthraquinone for 2 Years Toxicol Pathol, June 1, 2001; 29(4): 422 - 429. [Abstract] [PDF] |
||||
![]() |
H.-H. L. Hong, T. R. Devereux, R. L. Melnick, C. R. Moomaw, G. A. Boorman, and R. C. Sills Mutations of ras Protooncogenes and p53 Tumor Suppressor Gene in Cardiac Hemangiosarcomas from B6C3F1 Mice Exposed to 1,3-Butadiene for 2 Years Toxicol Pathol, July 1, 2000; 28(4): 529 - 534. [Abstract] [PDF] |
||||
![]() |
S. J. Culp, A. R. Warbritton, B. A. Smith, E. E. Li, and F. A. Beland DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene Carcinogenesis, July 1, 2000; 21(7): 1433 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Balmain and C. C.Harris Carcinogenesis in mouse and human cells: parallels and paradoxes Carcinogenesis, March 1, 2000; 21(3): 371 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Melnick, R. C. Sills, C. J. Portier, J. H. Roycroft, B. J. Chou, S. L. Grumbein, and R. A. Miller Multiple organ carcinogenicity of inhaled chloroprene (2-chloro-1,3-butadiene) in F344/N rats and B6C3F1 mice and comparison of dose–response with 1,3-butadiene in mice Carcinogenesis, May 1, 1999; 20(5): 867 - 878. [Abstract] [Full Text] [PDF] |
||||


